SCHEMBL8334091

SCHEMBL8334091

Oc1cncc(-c2ccccn2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.56
KDM4E B2RXH2 5/20 0.46
LMNA P02545 3/20 0.46
CCR1 P32246 3/20 0.46
CCR5 P51681 3/20 0.46
CCR8 P51685 3/20 0.46
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
METAP1 P53582 1/20 0.46
BLM P54132 1/20 0.46
HIF1A Q16665 1/20 0.46
DOHH Q9BU89 1/20 0.46
P4HTM Q9NXG6 1/20 0.46
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
GRM5 P41594 1/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
HSD17B1 P14061 3/20 0.43
CHEK2 O96017 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2462770 0.86 CYP2A6 (0.67) CYP2A6KDM4ELMNACCR1CCR5
Hydrochloric Acid SCHEMBL6004892 0.84 CYP2A6 (0.64) CYP2A6KDM4ELMNACCR1CCR5
SCHEMBL10031169 0.82 CYP2A6 (0.62) CYP2A6KDM4ELMNACCR1CCR5
SCHEMBL6067871 0.80 KDM4E (0.54) CYP2A6KDM4ELMNACCR1CCR5
SCHEMBL10031172 0.79 CYP2A6 (0.58) CYP2A6KDM4ELMNACCR1CCR5
SCHEMBL12925634 0.79 CYP2A6 (0.58) CYP2A6KDM4ELMNACCR1CCR5
SCHEMBL4187922 0.79 PKM (0.67) KDM4ELMNAGRM5NPC1RAB9A
SCHEMBL12068485 0.79 CYP2A6 (0.62) CYP2A6KDM4ELMNACCR1CCR5
Hydrochloric Acid SCHEMBL6068087 0.79 KDM4E (0.52) CYP2A6KDM4ELMNACCR1CCR5
SCHEMBL2121006 0.78 CYP2A6 (0.56) CYP2A6KDM4ELMNACCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060618-A1 Alkyne derivatives as tracers for metabotropic glutamate receptor binding MERCK & CO., INC. (US) 2007-03-15 US disclosed
WO-2004038374-A2 ALKYNE DERIVATIVES AS TRACERS FOR METABOTROPIC GLUTAMATE RECEPTOR BINDING MERCK & CO., INC. (US) 2004-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060618-A1 Alkyne derivatives as tracers for metabotropic glutamate receptor binding GRM5, GRM3, GRIK5 CYP2A6 1998/4885KDM4E 1767/4885LMNA 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.